Is Definium Therapeutics, Inc. (DFTX) a Buy, Sell, or Hold?
Definium Therapeutics, Inc.
NASDAQ:DFTX
$45.98 USD
$2.33 (5.34%)
- Volume
- 1.42M
- Average Volume
- 4.53M
- Market Capitalization
- $5.01B
- P/E Ratio
- -18.39
- Dividend Yield
- 0.00%
- Price Target
- $49.00
- Year High
- $49.20
- Year Low
- $12.88
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.69
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
23
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
14
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 188.73K
DFTX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
DFTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Sullivan Mark | officer: Chief Legal Officer | 2026-06-25 | S-Sale | 45.03 | 2026-06-26 |
| Roberts Brandi | officer: Chief Financial Officer | 2026-06-25 | S-Sale | 45.03 | 2026-06-26 |
| Barrow Robert | director, officer: Chief Executive Officer | 2026-06-25 | S-Sale | 45.03 | 2026-06-26 |
| Karlin Daniel | officer: Chief Medical Officer | 2026-06-25 | S-Sale | 45.03 | 2026-06-26 |
| Wiley Matthew T. | officer: Chief Commercial Officer | 2026-06-25 | S-Sale | 45.03 | 2026-06-26 |
| Wiley Matthew T. | officer: Chief Commercial Officer | 2026-06-22 | A-Award | 0 | 2026-06-22 |
| Barrow Robert | director, officer: Chief Executive Officer | 2026-06-22 | A-Award | 0 | 2026-06-22 |
| Sullivan Mark | officer: Chief Legal Officer | 2026-06-22 | A-Award | 0 | 2026-06-22 |
| Roberts Brandi | officer: Chief Financial Officer | 2026-06-22 | A-Award | 0 | 2026-06-22 |
| Karlin Daniel | officer: Chief Medical Officer | 2026-06-22 | A-Award | 0 | 2026-06-22 |
| CRYSTAL ROGER | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| CRYSTAL ROGER | director | 2026-06-11 | A-Award | 24.11 | 2026-06-15 |
| GRYSKA DAVID W | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| GRYSKA DAVID W | director | 2026-06-11 | A-Award | 24.11 | 2026-06-15 |
| Vallone Carol A | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Vallone Carol A | director | 2026-06-11 | A-Award | 24.11 | 2026-06-15 |
| Krebs Andreas | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Krebs Andreas | director | 2026-06-11 | A-Award | 24.11 | 2026-06-15 |
| Adsett Roger | director | 2026-06-11 | A-Award | 24.11 | 2026-06-15 |
| Adsett Roger | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Bruhn Suzanne Louise | director | 2026-06-11 | A-Award | 0 | 2026-06-15 |
| Bruhn Suzanne Louise | director | 2026-06-11 | A-Award | 24.11 | 2026-06-15 |
| Karlin Daniel | officer: Chief Medical Officer | 2026-03-25 | S-Sale | 18.47 | 2026-03-26 |
| Sullivan Mark | officer: Chief Legal Officer | 2026-03-25 | S-Sale | 18.47 | 2026-03-26 |
| Barrow Robert | director, officer: Chief Executive Officer | 2026-03-25 | S-Sale | 18.47 | 2026-03-26 |
| Wiley Matthew T. | officer: Chief Commercial Officer | 2026-02-03 | A-Award | 0 | 2026-02-05 |
| Roberts Brandi | officer: Chief Financial Officer | 2026-02-03 | A-Award | 0 | 2026-02-05 |
| Sullivan Mark | officer: Chief Legal Officer | 2026-02-03 | A-Award | 0 | 2026-02-05 |
| Karlin Daniel | officer: Chief Medical Officer | 2026-02-03 | A-Award | 0 | 2026-02-05 |
| Barrow Robert | director, officer: Chief Executive Officer | 2026-02-03 | A-Award | 0 | 2026-02-05 |
| Adsett Roger | director | 2026-01-29 | A-Award | 17.24 | 2026-01-29 |
| Adsett Roger | 2026-01-29 | 0 | 2026-01-29 | ||
| Karlin Daniel | officer: Chief Medical Officer | 2025-12-26 | S-Sale | 13.1469 | 2025-12-29 |
| Barrow Robert | director, officer: Chief Executive Officer | 2025-12-26 | S-Sale | 13.1469 | 2025-12-29 |
| Sullivan Mark | officer: Chief Legal Officer | 2025-12-26 | S-Sale | 13.1469 | 2025-12-29 |
| Sullivan Mark | officer: Chief Legal Officer | 2025-09-25 | S-Sale | 9.77 | 2025-09-26 |
| Barrow Robert | director, officer: Chief Executive Officer | 2025-09-25 | S-Sale | 9.77 | 2025-09-26 |
| Karlin Daniel | officer: Chief Medical Officer | 2025-09-25 | S-Sale | 9.77 | 2025-09-26 |
| Sullivan Mark | officer: Chief Legal Officer | 2025-06-25 | S-Sale | 6.8 | 2025-06-26 |
| Karlin Daniel | officer: Chief Medical Officer | 2025-06-25 | S-Sale | 6.8 | 2025-06-26 |
| Barrow Robert | director, officer: Chief Executive Officer | 2025-06-25 | S-Sale | 6.8 | 2025-06-26 |
| Krebs Andreas | director | 2025-06-12 | A-Award | 7.3 | 2025-06-16 |
| Vallone Carol A | director | 2025-06-12 | A-Award | 7.3 | 2025-06-16 |
| Bruhn Suzanne Louise | director | 2025-06-12 | A-Award | 7.3 | 2025-06-16 |
| CRYSTAL ROGER | director | 2025-06-12 | A-Award | 7.3 | 2025-06-16 |
| GRYSKA DAVID W | director | 2025-06-12 | A-Award | 7.3 | 2025-06-16 |
| Roberts Brandi | officer: Chief Financial Officer | 2025-06-02 | A-Award | 7.26 | 2025-06-02 |
| Roberts Brandi | 2025-06-02 | 0 | 2025-06-02 | ||
| Barrow Robert | director, officer: Chief Executive Officer | 2025-03-25 | S-Sale | 6.74 | 2025-03-26 |
| Karlin Daniel | officer: Chief Medical Officer | 2025-03-25 | S-Sale | 6.74 | 2025-03-26 |
| Sullivan Mark | officer: Chief Legal Officer | 2025-03-25 | S-Sale | 6.74 | 2025-03-26 |
| Liao Carrie | officer: Chief Accounting Officer | 2025-03-25 | S-Sale | 6.74 | 2025-03-26 |
| Wiley Matthew T. | officer: Chief Commercial Officer | 2025-03-17 | A-Award | 6.35 | 2025-03-18 |
| Wiley Matthew T. | 2025-03-17 | 0 | 2025-03-18 | ||
| Barrow Robert | director, officer: Chief Executive Officer | 2025-03-12 | A-Award | 0 | 2025-03-13 |
| Karlin Daniel | officer: Chief Medical Officer | 2025-03-12 | A-Award | 0 | 2025-03-13 |
| Sullivan Mark | officer: Chief Legal Officer | 2025-03-12 | A-Award | 0 | 2025-03-13 |
| Liao Carrie | officer: Chief Accounting Officer | 2025-03-12 | A-Award | 0 | 2025-03-13 |
| Barrow Robert | director, officer: Chief Executive Officer | 2024-12-26 | S-Sale | 7.43 | 2024-12-27 |
| Liao Carrie | officer: Chief Accounting Officer | 2024-12-26 | S-Sale | 7.43 | 2024-12-27 |
| Karlin Dan | officer: Chief Medical Officer | 2024-12-26 | S-Sale | 7.43 | 2024-12-27 |
| Sullivan Mark | officer: Chief Legal Officer | 2024-12-26 | S-Sale | 7.43 | 2024-12-27 |
| GRYSKA DAVID W | director | 2024-12-05 | P-Purchase | 7.17 | 2024-12-05 |
| Liao Carrie | officer: Chief Accounting Officer | 2024-09-25 | S-Sale | 5.98 | 2024-09-25 |
| Barrow Robert | director, officer: Chief Executive Officer | 2024-09-25 | S-Sale | 5.98 | 2024-09-25 |
| Karlin Dan | officer: Chief Medical Officer | 2024-09-25 | S-Sale | 5.98 | 2024-09-25 |
| Sullivan Mark | officer: Chief Legal Officer | 2024-09-25 | S-Sale | 5.98 | 2024-09-25 |
| GRYSKA DAVID W | director | 2024-08-23 | P-Purchase | 5.98 | 2024-08-26 |
| Halperin Wernli Miri | officer: Executive President | 2024-08-21 | M-Exempt | 3.7 | 2024-08-22 |
| Halperin Wernli Miri | officer: Executive President | 2024-08-21 | F-InKind | 6.17 | 2024-08-22 |
| Halperin Wernli Miri | officer: Executive President | 2024-08-21 | M-Exempt | 3.7 | 2024-08-22 |
| Barrow Robert | director, officer: Chief Executive Officer | 2024-08-20 | P-Purchase | 6.12 | 2024-08-20 |
| Barrow Robert | director, officer: Chief Executive Officer | 2024-08-19 | P-Purchase | 6.31 | 2024-08-20 |
| Karlin Dan | officer: Chief Medical Officer | 2024-06-25 | S-Sale | 7.22 | 2024-06-25 |
| Barrow Robert | director, officer: Chief Executive Officer | 2024-06-25 | S-Sale | 7.22 | 2024-06-25 |
| Sullivan Mark | officer: Chief Legal Officer | 2024-06-25 | S-Sale | 7.22 | 2024-06-25 |
| Vallone Carol A | director | 2024-06-10 | A-Award | 7.25 | 2024-06-12 |
| GRYSKA DAVID W | director | 2024-06-10 | A-Award | 7.25 | 2024-06-12 |
| CRYSTAL ROGER | director | 2024-06-10 | A-Award | 7.25 | 2024-06-12 |
| Bruhn Suzanne Louise | director | 2024-06-10 | A-Award | 7.25 | 2024-06-12 |
| Krebs Andreas | director | 2024-06-10 | A-Award | 7.25 | 2024-06-12 |
| Greenway Schond L. | officer: Chief Financial Officer | 2024-03-25 | F-InKind | 9.78 | 2024-03-26 |
| Karlin Dan | officer: Chief Medical Officer | 2024-03-25 | S-Sale | 9.5 | 2024-03-26 |
| Barrow Robert | director, officer: Chief Executive Officer | 2024-03-25 | S-Sale | 9.5 | 2024-03-26 |
| Wernli Miri Halperin | officer: Executive President | 2024-02-27 | A-Award | 4.98 | 2024-02-29 |
| Greenway Schond L. | officer: Chief Financial Officer | 2024-02-27 | A-Award | 4.98 | 2024-02-29 |
| Sullivan Mark | officer: Chief Legal Officer | 2024-02-27 | A-Award | 4.98 | 2024-02-29 |
| Karlin Dan | officer: Chief Medical Officer | 2024-02-27 | A-Award | 4.98 | 2024-02-29 |
| Liao Carrie | officer: Chief Accounting Officer | 2024-02-27 | A-Award | 4.98 | 2024-02-29 |
| Barrow Robert | director, officer: Chief Executive Officer | 2024-02-27 | A-Award | 4.98 | 2024-02-29 |
| Karlin Dan | officer: Chief Medical Officer | 2023-12-26 | S-Sale | 3.63 | 2023-12-26 |
| Barrow Robert | director, officer: Chief Executive Officer | 2023-12-26 | S-Sale | 3.63 | 2023-12-26 |
| Greenway Schond L. | officer: Chief Financial Officer | 2023-12-26 | S-Sale | 3.63 | 2023-12-26 |
| Barrow Robert | director, officer: Chief Executive Officer | 2023-09-25 | S-Sale | 3.57 | 2023-09-25 |
| Barrow Robert | director, officer: Chief Executive Officer | 2023-09-25 | S-Sale | 3.58 | 2023-09-25 |
| Karlin Dan | officer: Chief Medical Officer | 2023-09-25 | S-Sale | 3.57 | 2023-09-25 |
| Karlin Dan | officer: Chief Medical Officer | 2023-09-25 | S-Sale | 3.58 | 2023-09-25 |
| Greenway Schond L. | officer: Chief Financial Officer | 2023-09-25 | S-Sale | 3.57 | 2023-09-25 |
| Greenway Schond L. | officer: Chief Financial Officer | 2023-09-25 | S-Sale | 3.58 | 2023-09-25 |
| Greenway Schond L. | officer: Chief Financial Officer | 2023-08-25 | S-Sale | 3.8 | 2023-08-28 |